Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Naomasa Ioritani is active.

Publication


Featured researches published by Naomasa Ioritani.


The Journal of Urology | 1987

Clinical Application of Extracorporeal Shock Wave Lithotripsy using Microexplosions

Masaaki Kuwahara; Koichi Kambe; Seiichi Kurosu; Shizuichi Kageyama; Naomasa Ioritani; Seiichi Orikasa; Kazuyoshi Takayama

Extracorporeal stone disintegration using a chemical explosive (10 mg. lead azide) as an energy source of underwater shock waves was performed in 105 patients 11 to 72 years old who had stones in the upper urinary tract. We used a prototype disintegrator in this series. The over-all rate free of stones 3 months after treatment was 82 per cent. Shock wave therapy was performed alone in 77 patients (73 per cent), while the remainder required combined treatment with percutaneous and/or transurethral lithotripsy. The most common complications were colic pain (30 per cent) and fever (23 per cent). In 4 patients other complications, that is bacteremia, gastrointestinal bleeding, ureteral injury and subcapsular renal hematoma, were observed but they were treated conservatively with no serious adverse effects. Our study demonstrates the safe use of this method for clinical treatment.


International Journal of Urology | 2004

Health related quality of life in Japanese men after radical prostatectomy or radiation therapy for localized prostate cancer

Shunichi Namiki; Tatsuo Tochigi; Masaaki Kuwahara; Naomasa Ioritani; Akito Terai; Isao Numata; Makoto Satoh; Seiichi Saito; Nobuo Koinuma; Yoichi Arai

Abstractu2003 Background:u2002 We performed a retrospective survey of general and disease specific health‐related quality of life (HRQOL) after radical prostatectomy (RP) and external beam radiotherapy (XRT) in Japanese men.


International Journal of Urology | 2004

Recovery of health related quality of life after radical prostatectomy in Japanese men: A longitudinal study

Shunichi Namiki; Tatsuo Tochigi; Masaaki Kuwahara; Naomasa Ioritani; Koji Yoshimura; Akito Terai; Haruo Nakagawa; Shigeto Ishidoya; Makoto Satoh; Akihiro Ito; Seiichi Saito; Nobuo Koinuma; Yoichi Arai

Abstract Background: We performed a longitudinal survey of health related quality of life (HRQOL) after radical retropubic prostatectomy (RP) in Japanese men with localized prostate cancer.


Japanese Journal of Cancer Research | 2000

Mechanism of Anti-tumor Effect of Combination of Bleomycin and Shock Waves

Masanori Kato; Naomasa Ioritani; Takashi Suzuki; Mariko Kambe; Yasuo Inaba; Ryuji Watanabe; Hironobu Sasano; Seiichi Orikasa

We have previously reported marked enhancement of the cytocidal effect of bleomycin (BLM) on cancer cell suspensions in vitro by the combination with shock waves. In this study, we evaluated the synergistic effects on cancer cell proliferation and apoptosis in solid tumors. A spherical piezoceramic element was used as the shock wave source, with a pressure peak of 40 MPa. A human colon cancer cell line, SW480 was implanted onto the back of nude mice. Two thousand shock waves were administered to the tumor immediately following an intravenous injection of BLM at a dose of one‐tenth of the LD50. The tumor was extirpated at 3, 6, 12, 24, 72 h and 1 week following shock exposure. Cell proliferation and apoptosis were detected by Ki‐67 using antibody MIB‐1 and by the terminal deoxynucleotidyl transferase (TdT)‐mediated dUTP‐biotin nick‐end labeling (TUNEL) method. The lowest percentage (35.7%) of Ki‐67‐positive cells appeared 24 h following the treatment. The maximum apoptotic index was detected within 6 h following the treatment. Moreover, numerous large cells with enlarged nuclei were detected histologically. These results suggest that shock waves may enhance chemotherapeutic effects by increasing apoptosis and decreasing cell proliferation in the tumor tissue.


Japanese Journal of Clinical Oncology | 2013

Intravesical Seeding of Upper Urinary Tract Urothelial Carcinoma Cells During Nephroureterectomy: An Exploratory Analysis from the THPMG Trial

Akihiro Ito; Ichiro Shintaku; Makoto Satoh; Naomasa Ioritani; Tatsuo Tochigi; Isao Numata; Takashige Namima; Koichi Kambe; Atsushi Kyan; Seiji Ueno; Hisanobu Adachi; Shinichi Yamashita; Takuhiro Yamaguchi; Yoichi Arai

OBJECTIVEnThe Pirarubicin Monotherapy Study Group trial was a randomized Phase II study that evaluated the efficacy of intravesical instillation of pirarubicin in the prevention of bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma. This study conducted further analysis of the Pirarubicin Monotherapy Study Group cohort, focusing on intravesical seeding of cancer cells.nnnMETHODSnUsing the data from the Pirarubicin Monotherapy Study Group trial, bladder recurrence-free survival rates and factors associated with bladder recurrence in the control group were analyzed.nnnRESULTSnOf 36 patients in the control group, 14 with positive urine cytology had more frequent recurrence when compared with the 22 patients with negative cytology (P = 0.004). Based on the multivariate analysis in the control group, voided urine cytology was an independent predictive factor of bladder recurrence (hazard ratio, 5.54; 95% confidence interval 1.12-27.5; P = 0.036). Of 72 patients in the Pirarubicin Monotherapy Study Group trial, 31 had positive urine cytology. Among the 31 patients, 17 patients who received pirarubicin instillation had fewer recurrences when compared with 14 patients who received control treatment (P = 0.0001). On multivariate analysis, pirarubicin instillation was an independent predictor of better recurrence-free survival rates in the patients with positive urine cytology (hazard ratio, 0.02; 95% confidence interval, 0.00-0.53; P = 0.018). Of 21 patients with bladder recurrence, 17 had recurrent tumor around cystotomy or in the bladder neck compromised by the urethral catheter, supporting the notion that tumor cells seeded in the injured urothelium.nnnCONCLUSIONSnIntravesical instillation of pirarubicin immediately after nephroureterectomy significantly reduced the bladder recurrence rate in patients with positive voided urine cytology. The results suggest that intravesical seeding of upper urinary tract urothelial carcinoma occurs during nephroureterectomy.


International Journal of Urology | 2007

Impact of salvage therapy for biochemical recurrence on health-related quality of life following radical prostatectomy

Shunichi Namiki; Seiichi Saito; Tatsuo Tochigi; Naomasa Ioritani; Akito Terai; Yoichi Arai

Objective:u2003 To determine the impact of salvage therapy for prostate‐specific antigen (PSA) recurrence on the health‐related quality of life (HRQOL) of patients after radical retropubic prostatectomy (RP).


International Journal of Urology | 2003

Health‐related quality of life after radical prostatectomy in Japanese men with localized prostate cancer

Shunichi Namiki; Tatsuo Tochigi; Masaaki Kuwahara; Tetsutaro Ohnuma; Naomasa Ioritani; Fumihiko Soma; Ichiro Shintaku; Akito Terai; Haruo Nakagawa; Makoto Satoh; Seiichi Saito; Nobuo Koinuma; Yoichi Arai

Purpose:u2002 We evaluated retrospectively health‐related quality of life (HRQOL) after radical prostatectomy (RP) in Japanese men with localized prostate cancer.


Current topics in shock waves 17th international symposium on shock waves and shock tubes | 2008

Renal tissue damage induced by focused shock waves

Naomasa Ioritani; Masaaki Kuwahara; Koichi Kambe; Katsuyuki Taguchi; Toshinori Saitoh; S. Shirai; Seiichi Orikasa; Kazuyoshi Takayama; P. A. Lush

Biological evidence of renal arterial wall damage induced by the microjet due to shock wave‐cavitation bubble interaction was demonstrated in living dog kidneys. We also intended to clarify the mechanism of renal tissue damage and the effects of different conditions of shock wave exposure (peak pressure of focused area, number of shots, exposure rate) on the renal tissue damage in comparison to stone disintegration.Disruption of arterial wall was the most remarkable histological change in the focused area of the kidneys. This lesion appeared as if the wall had been punctured by a needle. Large hematoma formation in the renal parenchym, and interstitial hemorrhage seemed to be the results of the arterial lesion. This arterial disorder also led to ischemic necrosis of the tubules surrounding the hematoma. Micro‐angiographic examination of extracted kidneys also proved such arterial puncture lesions and ischemic lesions.The number of shots required for model stone disintegration was not inversely proportiona...


Shock Waves | 1991

Anti-miss-shot control device for selective stone disintegration in extracorporeal shock wave lithotripsy

Masaaki Kuwahara; Naomasa Ioritani; Koichi Kambe; Seiichi Orikasa; Kazuyoshi Takayama

A new device to prevent erroneously focused shock waves to the renal parenchyma during extracorporeal shock wave lithotripsy (ESWL) has been developed; an anti-miss-shot control device (AMCD) and experiments have been conducted to evaluate its effectiveness. For shock wave generation and stone localization, piezoceramic elements (PSE) and ultrasound localization, respectively were used. After stone localization, probing ultrasounds (PU) were emmitted from the PSE towards the focal region and the reflected sound levels (RSL) were monitored by the PSE which also functioned as a microphone. A direct hit by the PU to the stone or a miss was judged from the RSL, i.e. a high RSL indicates a direct hit and a low RSL indicates a miss. Shock waves were generated only when the RSL exceeded the level which indicated a direct hit. The experimental results showed that the injury to the renal parenchyma was decreased by using the AMCD. Clinical application of the AMCD is expected to increase the safety of ESWL.


International Journal of Urology | 2000

Extracorporeal shock wave lithotripsy for a ureteral stone in crossed fused renal ectopia

Masanori Kato; Naomasa Ioritani; Masataka Aizawa; Yasuo Inaba; Ryuji Watanabe; Seiichi Orikasa

Abstract Background: A 63‐year‐old woman presented with right flank pain and macroscopic hematuria.

Collaboration


Dive into the Naomasa Ioritani's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Seiichi Saito

University of the Ryukyus

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge